Establishment Labs Holdings Inc
NASDAQ:ESTA

Watchlist Manager
Establishment Labs Holdings Inc Logo
Establishment Labs Holdings Inc
NASDAQ:ESTA
Watchlist
Price: 47.28 USD 0.98% Market Closed
Market Cap: 1.3B USD
Have any thoughts about
Establishment Labs Holdings Inc?
Write Note

Establishment Labs Holdings Inc
Free Cash Flow

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Establishment Labs Holdings Inc
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
Establishment Labs Holdings Inc
NASDAQ:ESTA
Free Cash Flow
-$64.3m
CAGR 3-Years
-46%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
No Stocks Found

Establishment Labs Holdings Inc
Glance View

Market Cap
1.3B USD
Industry
Health Care

Established at the intersection of innovation and aesthetics, Establishment Labs Holdings Inc. has carved a niche in the global medical technology landscape. Founded in 2004, this Costa Rica-based company has painstakingly built a reputation for its cutting-edge silicone breast implants and medical devices aimed at breast aesthetics and reconstruction. The company leverages advanced technology to deliver safer and more natural products, primarily through its signature Motiva Implants® brand. With its commitment to safety, quality, and innovation, Establishment Labs has successfully expanded into more than 80 countries, earning trust by catering to surgeons and patients with an ever-evolving portfolio of aesthetically driven solutions. Establishment Labs’ business model is intricately tied to the nuances of the cosmetic surgery industry, where product differentiation and regulatory compliance are paramount. The company invests heavily in research and development, focusing on creating next-generation breast implant technologies that prioritize patient safety and satisfaction. Revenue streams are driven by direct sales to plastic surgeons and healthcare providers, capitalizing on growing global demand for aesthetic procedures. Additionally, the company stays ahead of the competition by fostering strong relationships with medical professionals and continuously educating them about the benefits and capabilities of its innovative product offerings. This strategic alliance strengthens its market presence and aids consistent revenue growth, reinforcing its status as a forward-thinking leader in the medical aesthetics field.

ESTA Intrinsic Value
25.98 USD
Overvaluation 45%
Intrinsic Value
Price

See Also

What is Establishment Labs Holdings Inc's Free Cash Flow?
Free Cash Flow
-64.3m USD

Based on the financial report for Sep 30, 2024, Establishment Labs Holdings Inc's Free Cash Flow amounts to -64.3m USD.

What is Establishment Labs Holdings Inc's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
-10%

Over the last year, the Free Cash Flow growth was 48%. The average annual Free Cash Flow growth rates for Establishment Labs Holdings Inc have been -46% over the past three years , -10% over the past five years .

Back to Top